BioNTech SE (FRA:22UA)
Germany · Delayed Price · Currency is EUR 96.65
-1.40 (-1.43%)
Jan 30, 2026, 10:58 AM CET
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of €24.02 billion as of January 30, 2026. Its market cap has decreased by -9.29% in one year.
Market Cap
24.02B
Enterprise Value
9.92B
Revenue
3.15B
Ranking
n/a
PE Ratio
n/a
Stock Price
€96.65
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from 2.72B to 24.02B, an increase of 783.06%. That is a compound annual growth rate of 41.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 24.02B | 23.23% |
| Dec 31, 2025 | 19.50B | -26.11% |
| Dec 31, 2024 | 26.39B | 16.25% |
| Dec 29, 2023 | 22.70B | -33.55% |
| Dec 30, 2022 | 34.16B | -37.61% |
| Dec 31, 2021 | 54.75B | 241.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 54.59B |
| Siemens Healthineers AG | 47.05B |
| Bayer Aktiengesellschaft | 43.78B |
| Fresenius SE & Co. KGaA | 26.59B |
| Sartorius Aktiengesellschaft | 14.69B |
| Fresenius Medical Care AG | 10.52B |
| Fielmann Group AG | 3.48B |
| Carl Zeiss Meditec AG | 2.45B |